Connor, Clark & Lunn Investment Management Ltd. Biote Corp. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Biote Corp. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 16,462 shares of BTMD stock, worth $48,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,462Holding current value
$48,069% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
92Shares Held
16.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$13.3 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$7.11 Million2.95% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.12 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA685KShares$2 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $22.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...